Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 35: 127781, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33422604

ABSTRACT

Sulfahydantoin-based molecules may provide a means to counteract antibiotic resistance, which is on the rise. These molecules may act as inhibitors of ß-lactamase enzymes, which are key in some resistance mechanisms. In this paper, we report on the synthesis of 6 novel sulfahydantoin derivatives by the key reaction of chlorosulfonyl isocyanate to form α-amino acid derived sulfamides, and their cyclization into sulfahydantoins. The synthesis is rapid and provides the target compounds in 8 steps. We investigated their potential as ß-lactamase inhibitors using two common Class A ß-lactamases, TEM-1 and the prevalent extended-spectrum TEM-15. Two compounds, 3 and 6, show substantial inhibition of the ß-lactamases with IC50 values between 130 and 510 µM and inferred Ki values between 32 and 55 µM.


Subject(s)
Drug Development , Sulfur Compounds/pharmacology , beta-Lactamase Inhibitors/pharmacology , beta-Lactamases/metabolism , Dose-Response Relationship, Drug , Humans , Molecular Structure , Structure-Activity Relationship , Sulfur Compounds/chemical synthesis , Sulfur Compounds/chemistry , beta-Lactamase Inhibitors/chemical synthesis , beta-Lactamase Inhibitors/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...